Madopar

Madopar

A brand name for LEVODOPA in combination with BENSERAZIDE.
References in periodicals archive ?
Tenders are invited for Renewal of Salempur Bartha Bareji to Madopar link road
Madopar HBS, a controlled release as well as a gastroretentive dosage form, was employed to analyze the performance of IPB and PXLNET gastroretentive drug delivery systems.
Increased life expectancy resulting from addition of L-deprenyl to Madopar treatment in Parkinson's disease: a longterm study.
Medications were converted into an equivalent dose of immediate-release levodopa (Madopar, Roche, Basel, Switzerland), according to the following formula: 100 mg immediate-release levodopa = 133 mg controlled-release levodopa = 1 mg pramipexole = 100 mg piribedil = 10 mg selegiline; each dose of levodopa was 25% more effective with entacapone.
Commonly used medications include: * Levodopa, examples: Sinemet, Stalevo, Madopar. This medication is the most frequently-used drug in managing Parkinson's symptoms.
Wei, "Effect of Madopar Combine with herbal medicine on the Tyrosine hydroxylase (TH) and TH mRNA of rats with Parkinson's disease," Chinese Journal of Gerontology, vol.
Invida will manage all of the marketing and sales activities for Roche's primary care products, including Xenical and Roaccutane, as well as products from Roche's CNS portfolio, including Madopar for the treatment of Parkinson's disease and Rivotril for epilepsy and Valium.
In 1997, Argentine authorities discovered several fake lots of Madopar, a medication for Parkinson's disease.
Medical and Surgical Treatment for Parkinson's Disease Drug Therapy Benefit and Use Levodopa with carbidopa Used as first-line treatment for Sinemet CR (controlled release) many patients; improvement in Standard Sinemet (immediate mobility and activities of daily release) * living and, in some cases, mood; Levodopa with benserazide fewer side effects with con- (unavailable in USA) trolled-release preparations; Prolopa, Madopar frequently used in combination with COMT inhibitor and/or dopamine agonist.
During the period before this investigation, the patients had been treated with 300-400 mg of L-dopa (Madopar [R]) per day orally.
The other one had been diagnosed with PD and treated with Madopar for 3 years.